Workflow
Globenewswire
icon
搜索文档
Beyond Meat Announces Final Tender Results and Final Settlement for Exchange Offer and Consent Solicitation with Respect to Existing Convertible Notes
Globenewswire· 2025-10-29 19:00
EL SEGUNDO, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Beyond Meat, Inc. (NASDAQ: BYND) (the “Company” or “Beyond Meat”), a leader in plant-based meat, today announced the final tender results of its previously announced exchange offer (the “Exchange Offer”) to exchange any and all of its 0% Convertible Senior Notes due 2027 (the “Existing Convertible Notes”) for a pro rata portion of (i) up to $202.5 million in aggregate principal amount of its new 7.00% Convertible Senior Secured Second Lien PIK Toggle Not ...
Chicago Atlantic BDC, Inc. Announces Third Quarter 2025 Financial Results Conference Call
Globenewswire· 2025-10-29 19:00
NEW YORK, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Chicago Atlantic BDC, Inc. (the “Company”) (NASDAQ: LIEN), a specialty finance company that has elected to be regulated as a business development company, today announced details for the release of its financial results for the third quarter ended September 30, 2025. The Company plans to release its financial results for the third quarter ended September 30, 2025 before the market opens on Thursday, November 13, 2025, and host a conference call and live audio webc ...
Oatly Reports Third Quarter 2025 Financial Results
Globenewswire· 2025-10-29 19:00
MALMÖ, Sweden, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Oatly Group AB (Nasdaq: OTLY) (“Oatly”, the “Company” or the “Group”), the world’s original and largest oat drink company, today announced financial results for the third quarter ended September 30, 2025. Jean-Christophe Flatin, Oatly’s CEO, commented, “I am proud to report that we drove profitable growth in the quarter, with solid constant currency revenue growth and positive adjusted EBITDA. Achieving this milestone reflects the disciplined, strategic actio ...
Lifecore Biomedical Selected as New Commercial Manufacturing Partner by Leading Global Pharmaceutical Company
Globenewswire· 2025-10-29 19:00
Lifecore to Execute Commercial Site Transfer and Become New Supplier of Choice for Leading Commercial Injectable Pharmaceutical Product Represents Second Agreement Signed with Same Major Multinational Organization in Recent Months Separate Pre-Clinical Formulation Development Agreement Signed with New Early-Stage Biotech Customer CHASKA, Minn., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CD ...
Apuiat Wind Farm Reaches Commercial Operation – Marking a New Energy Era in Quebec
Globenewswire· 2025-10-29 19:00
UASHAT, Canada, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Apuiat Wind Farm L.P., a 50-50 partnership between the Innu communities and Boralex Inc., is proud to announce that the Apuiat Wind Farm has reached commercial operation. The 200 MW facility is located on the Nitassinan (traditional territory) of the Uashat mak Mani-utenam First Nation. The wind project was initiated and co-developed by the Innu communities. It stands as their first national energy project and the first wind farm to be built in Québec’s Côte ...
XORTX Announces Closing of US$1.1 Million Registered Direct Offering
Globenewswire· 2025-10-29 19:00
CALGARY, Alberta, Oct. 29, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late-stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and progressive kidney disease, announces that it has closed its registered direct offering announced on October 21, 2025, for the purchase and sale of 1,750,000 common shares (the “Common Shares”) (or pre-funded warrants (the “Pre-Funded Warrants”) in lieu the ...
Kamada to Present at the Stifel 2025 Healthcare Conference
Globenewswire· 2025-10-29 19:00
REHOVOT, Israel and Hoboken, N.J., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Kamada Ltd. (NASDAQ: KMDA; TASE: KMDA.TA), a global biopharmaceutical company with a portfolio of marketed products indicated for rare and serious conditions and a leader in the specialty plasma-derived field, today announced that Amir London, Chief Executive Officer, will participate in the Stifel 2025 Healthcare Conference, to be held to be held at the Lotte New York Palace Hotel, New-York, NY on November 11–13, 2025. Mr. London is sched ...
Conavi Medical announces agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund
Globenewswire· 2025-10-29 19:00
TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) (“Conavi” or the “Company”), a commercial-stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide minimally invasive cardiovascular procedures, is pleased to announce that it has entered into an agreement with the Province of Ontario as part of the Life Sciences Scale-Up Fund (LSSUF). LSSUF provides financial support to help small-to-medium sized enterprises based ...
Revival Gold Intersects 3.0 g/t Gold Over 21.1 Meters at Mercur and Mobilizes Fourth Rig to Beartrack-Arnett
Globenewswire· 2025-10-29 19:00
TORONTO, Oct. 29, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) (“Revival Gold” or the “Company”) is pleased to provide an update on the ongoing drilling program at the Company’s Mercur Gold Project (“Mercur”) in Utah and the Beartrack-Arnett Gold Project (“Beartrack-Arnett”) in Idaho. Highlights Mobilized a new core rig to Beartrack-Arnett bringing the total number of rigs drilling on the Company’s projects to four.At Mercur, received assay results from 16 additional drill holes with ...
ADMA Biologics to Report Third Quarter 2025 Financial Results on November 5, 2025
Globenewswire· 2025-10-29 19:00
RAMSEY, N.J. and BOCA RATON, Fla., Oct. 29, 2025 (GLOBE NEWSWIRE) -- ADMA Biologics, Inc. (Nasdaq: ADMA) (“ADMA” or the “Company”), a U.S. based, end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty biologics, today announced that it will report third quarter 2025 financial results on November 5, 2025, after the U.S. financial markets close. ADMA’s management team will host a live conference call and audio webcast on that date at 4:30 p.m. ET to disc ...